Serum vascular endothelial growth factor inpatients with head and neck squamous cell carcinoma

Clinical Otolaryngology and Allied Sciences

Volumn 24, Issue 5, 1999, Pages 426-430

  Homer, Jarrod J ^a,b   Anyanwu, K ^a   Ell, S R ^a   Greenman, J ^a   Stafford, N D ^a  

^a UNIVERSITY OF HULL   (United Kingdom)

^b NONE   (United Kingdom)

Author keywords

Angiogenesis; Head and neck carcinoma; Vascular endothelial growth factor

Indexed keywords

CYTOKINE; VASCULOTROPIN;

ADULT; ARTICLE; BLOOD LEVEL; CANCER STAGING; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; HEAD AND NECK CARCINOMA; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; THROMBOCYTE AGGREGATION;

AGED; CARCINOMA, SQUAMOUS CELL; ENDOTHELIUM, VASCULAR; FEMALE; GROWTH SUBSTANCES; HEAD AND NECK NEOPLASMS; HUMANS; MALE; NEOPLASM STAGING;

EID: 0032884417     PISSN: 03077772     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2273.1999.00282.x     Document Type: Article

References (47)

1. FOLKMAN J. (1990) What is the evidence that tumors are angiogenesis dependent? J. Nat. Cancer Inst. 82, 4-6
2. KUMAR H., HEER K., LEE P.W.R. et al. (1998) Preoperative Serum Vascular Endothelial Growth Factor can predict stage in colorectal cancer. Clin. Cancer Res. 4, 1279-1285
3. DIRIX L.Y., VERMEULEN P.B., PROVE A. et al. (1997) Elevated levels of the angiogenic cytokines basic fibroblast growth factor and vascular endothelial growth factor in sera of cancer patients. Br. J. Cancer 76, 238-243
4. TAKANO S., YOSHI Y., KONDO S. et al. (1996) Concentration of vascular endothelial growth factor in the serum and tumour tissue of brain tumour patients. Cancer Res. 56, 2185-2190
5. KONDO S., ASANO M., MATSUO K. et al. (1994) Vascular endothelial growth factor/vascular permeability factor is detectable in sera of tumor-bearing mice and cancer patients. Biochem. Biophys. Acta 1221, 211-214
6. YAMAMOTO Y., TOI M., KONDO S. et al. (1996) Concentrations of Vascular Endothelial Growth Factor in the sera of Normal Controls and Cancer Patients. Clin. Cancer Res. 2, 821-826
7. FUJISAKI K., MITSUYAMA K., TOYONAGA A. et al. (1998) Circulating vascular endothelial growth factor in patients with colorectal cancer. Am. J. Gastroenterol. 93, 249-252
8. PETRUZZELLI G.P., BENEFIELD J., TAITZ A.D. et al. (1997) Heparin-binding growth factors derived from head and neck squamous cell carcinomas induce endothelial cell proliferation. Head Neck 19, 576-582
9. EISMA R.J., SPIRO J.D. & KRFUTZNER D.L. (1997) Vascular Endothelial Growth Factor expression in head and neck squamous cell carcinoma. Am. J. Surg. 174, 513-517
10. SALVEN P., HEIKKILA P., ANTONEN A. et al. (1997) Vascular endothelial growth factor in squamous cell head and neck carcinoma expression and prognostic significance. Mod. Pathol. 10, 1128-1133
11. MORIYAMA M., KUMAGI S., KAWASHIRI S. et al. (1997) Immunohistochemical study of tumour angiogenesis in oral squamous cell carcinoma. Clin. Oncol. 33, 396-374
12. DENHART B.C., GUIDI A.J., TOGNAZZI K. et al(1997) Vascular permeability factor/vascular endothelial growth factor and its receptors in oral and laryngeal squamous cell carcinoma and dysplasia. Lab. Invest. 77, 659-664
13. WEBB N.J.A., BOTTOMLEY M.J., WATSON C.J. et al(1998; Vascular endothelial growth factor (VEGF) is released from platelets during blood clotting: implications for measurement of circulating VEGF levels in clinical disease. Clin. Sci. 94, 395-404
14. SOBIN L.H. & WITTEKIND CH., eds. (1997) TNM Classification of Malignant Tumours. John Wiley and Sons, New York
15. YOSHIMURA Y., OKA M. & HARADA T. (1990) Squamous cell carcinoma-antigen for detection of squamous cell and muco-epidermoid carcinoma after preliminary treatment. J. Oral Maxillofac. Surg. 48, 1288-1292
16. WALTHER E.K., DAHLMANN N. & GORGULLA H.T. (1993) Tumor markers in the diagnosis and follow-up of head and neck cancer: role of CEA, CA 19.9, SCC, TK and DTTPase. Head Neck 15, 230-235
17. BONGFRS V., BRAAKHUIS B.J.M. & SNOW G.B. (1995) Circulating fragments of cytokeratin 19 in patients with head and neck squamous cell carcinoma. Clin. Otolaryngol. 20, 479-482
18. YEN T.C., LIN W.Y., KAO C.H. et al. (1998) A study of a new tumour marker, CYFRA-21, in squamous cell carcinoma of the head and neck, and comparison with squamous cell carcinoma antigen. Clin. Otolaryngol. 23, 82-86
19. STRAKA M.B., WAGNER R.L., JOHNSON J.T. et al. (1992) The lack of utility of a tumor marker panel in head and neck carcinoma. Arch. Otolaryngol. Head Neck Surg. 118, 802-805
20. ROPKA D., GOODWIN J., LEVINE P.A. et al. (1991) Selective head and neck tumor markers. Arch. Otolaryngol. Head Neck Surg. 117, 1011-1014
21. MAXIM P.E. & VFLTRI R.W. (1986) Serum ferritin as a tumor marker in patients with squamous cell carcinoma of the head and neck. Cancer 57, 305-311
22. FERRARA N. & HENZEL W.J. (1989) Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem. Biophys. Res. Commun. 161, 851-858
23. SENGER D.R., GALLI S.J., DVORAK A.M. et al. (1983) Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 219, 983-985
24. HOUCK K.A., FERRARA N., WINER J. et al. (1991) The vascular endothelial growth family. Identification of a fourth molecular species and characterisation of alternate splicing of RNA. Mol. Endocrinol. 5, 1806-1814
25. FERRARA N. (1996) Vascular Endothelial Growth factor. Eur. J. Cancer 32A, 2413-2422
26. DE VRIES C., ESCOBEDO J.A., UENO H. et al. (1992) The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science 255, 989-991
27. MILLAUER B., WIZIGMANN V., SCHMURCH H. et al. (1993) High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis. Cell 72, 835-846
28. BROGI E., SCHATTEMAN G., WU T. et al. (1996) Hypoxia-induced Paracrine Regulation of Vascular Endothelial Growth Factor Receptor Expression. J. Clin. Invest. 97, 469-476
29. RAK J., FILMUS J., FINKZELLER G. et al.(1995) Oncogenes as inducers of tumor angiogenesis. Cancer Metast. Rev. 14, 263-277
30. KIESER A., WEICH H., BRANDNER G. et al. (1994) Mutant p53 potentiates protein kinase C induction of vascular endothelial growth factor expression. Oncogene 9, 963-969
31. COHEN T., NAHARI D., CEREM L.W. et al. (1996) Interleukin 6 induces the expression of vascular endothelial growth factor. J. Biol. Chem. 271, 736-741
32. BEN-AV P., CROFFORD L.J., WILDER R.L. et al. (1995) Induction of vascular endothelial growth factor expression in synovial fibroblasts by prostaglandin E and interleukin-1: a potential mechanism for inflammatory angiogenesis. FEBS Lett. 372, 83-87
33. DONOVAN D., HARMEY J.H., TOOMEY D. et al. (1997) TGF-b regulation of VEGF production by breast cancer cells. Ann. Surg. Oncol. 4, 621-627
34. BANKS R.E., FORBES M.A., KINSEY S.E. et al. (1998; Release of angiogenic cytokine vascular endothelial growth factor (VEGF) from platelets: significance for VEGF measurements and cancer biology. Br. J. Cancer 77, 956-964
35. KENDALL R.J. & THOMAS K.A. (1993) Inhibition of vascular endothelial growth factor activity by an endogenously encoded soluble receptor. Proc. Natl. Acad. Sci. USA 90, 10705-10709
36. HEER K., KUMAR H., SPEIRS V. et al. (1998) Vascular endothelial growth factor in premenopausal women-indicator of the best time for breast cancer surgery? Br. J. Cancer 78, 1203-1207
37. SHWEIKI D., ITIN A., NEUFELD G. et al. (1993; Patterns of expression of vascular endothelial growth factor (VEGF) and VEGF receptors in mice suggest a role in hormonally regulated angiogenesis. J. Clin. Invest. 91, 2235-2243
38. GASIC G.J. (1984) Role of plasma, platelets, and endothelial cells in tumor metastasis. Cancer Metast. Rev. 3, 99-114
39. BASTIDA E. & ORDINAS A. (1988) Platelet contribution to the formation of metastatic foci: the role of cancer cell-induced platelet activation. Haemostasis 18, 29-36
40. GRIGNANI G., PACCHIARINI L., RICETTI M.M. et al. (1989) Mechanisms of platelet activation by cultured human cancer cells and cells freshly isolated from tumor tissues. Invasion Metast. 9, 298-309
41. HELLAND I.B., KLEMENTSEN B. & JORGENSEN I. (1997) Addition of both platelets and thrombin in combination accelerates tumor cells to adhere to endothelial cells in vitro. In Vitro Cellular Dev. Biol. 33, 182-186
42. OLEKSOWICZ L. & DUTCHER J.P. (1995) Adhesive receptors expressed by tumor cells and platelets: novel targets for therapeutic anti-metastatic strategies. Med. Oncol. 12, 95-102
43. HUANG G.W., NONG H.T., YU Q.I. et al. (1997) Platelet aggregation in head and neck tumors in China. Laryngoscope 107, 1142-1145
44. SHOI M., HANCOCK W.W., ABF K. et al. (1998) Activation of coagulation and angiogenesis in cancer. Am. J. Path. 152, 399-411
45. TOI M., INADA K., SUZUKI H. et al. (1995) Tumor angiogenesis in breast cancer: its importance as a prognostic indicator and the association with vascular endothelial growth factor expression. Breast Cancer Res. Treat. 36, 193-204
46. TAKAHASHI Y., KITADAI Y., BUCANA C.D. et al. (1995) Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer. Cancer Res. 55, 3964-3968
47. PETRUZZELLI G.P. (1996) Tumor angiogenesis. Head Neck 18, 283-291